ChemMedChem · 2014 · 174 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionLigand BindingMolecular DockingProtein StructureProtein-ligand DockingStructure-activity Relationship AnalysisBinding Mode AnalysisBinding Mode OptimizationBinding Mode PredictionChemical Structure-activity RelationshipsLigand Orientation EffectsProtein-ligand Complex ModelingStructure-based Ligand Design
An X-ray crystal structure of Kelch-like ECH-associated protein (Keap1) co-crystallised with (1S,2R)-2-[(1S)-1-[(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-carbonyl]cyclohexane-1-carboxylic acid (compound (S,R,S)-1 a) was obtained. This X-ray crystal structure provides breakthrough experimental evidence for the true binding mode of the hit compound (S,R,S)-1 a, as the ligand orientation was found to differ from that of the initial docking model, which was available at the start of the project. Crystallographic elucidation of this binding mode helped to focus and drive the drug design process more effectively and efficiently.
16
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
Shih‐Ching Lo, Xuchu Li, Michael T. Henzl et al. · The EMBO Journal · 2006 · 569 citations · Full text